508 results on '"Matano, Tetsuro"'
Search Results
52. Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells
53. Predictors associated with a better response to the Japanese aluminum‐free hepatitis A vaccine, Aimmugen ® , for people living with HIV
54. Nef‐specific CD107a+ CD4+ T‐cell responses in a rhesus macaque (Macaca mulatta) showing partial simian immunodeficiency virus control following passive neutralizing antibody infusion
55. Augmentation of anti-simian immunodeficiency virus activity in CD8+ cells by neutralizing but not nonneutralizing antibodies in the acute phase
56. Divergence and diversity of ULBP2 genes in rhesus and cynomolgus macaques
57. LASTING SIV CONTROL BY MULTIPLE GAG, VIF, AND NEF EPITOPE-SPECIFIC CD8+ T CELLS: O6.04
58. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation
59. Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections
60. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
61. Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
62. On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19
63. Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused simian immunodeficiency virus controllers
64. REINFORCEMENT OF CD8+ CELL CAPACITY TO CONTROL VIRAL REPLICATION BY THERAPEUTIC VACCINATION UNDER ANTIRETROVIRAL THERAPY IN SIV-INFECTED RHESUS MACAQUES: ABSTRACT #9
65. Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Neutralization-Resistant SIVsmE543-3 Infection
66. Dysbiotic Fecal Microbiome in HIV-1 Infected Individuals in Ghana
67. Association ofHLA‐ DRB1 *09:01with severe COVID ‐19
68. Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates
69. Diversity of MHC class I haplotypes in cynomolgus macaques
70. Infection and Pathogenicity of Chimeric Simian-Human Immunodeficiency Viruses in Macaques: Determinants of High Virus Loads and CD4 Cell Killing
71. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B
72. ULBP4/RAET1E is highly polymorphic in the Old World monkey
73. Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques
74. Immunogenicity of DNA and recombinant Sendai virus vaccines expressing the HIV-1 gag gene
75. A Potent Anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germ Line Immunoglobulin Gene Polymorphism in Rhesus Macaques
76. Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan
77. Fecal Microbiome Composition in Healthy Adults in Ghana
78. Neutralizing Antibody-Independent SARS-CoV-2 Control Correlated with Intranasal Vaccine-Induced CD8 + T-Cell Responses
79. Reduced Resistance of SARS-CoV-2 Variants Toward Affinity-Matured Serological Immunity
80. Estimating HIV-1 incidence in Japan from the proportion of recent infections
81. Myeloid cell dynamics correlate with clinical outcomes of severe coronavirus disease 2019
82. Gut-Homing CD4+ T Cells Are Associated with the Activity of Gastritis in HIV-Infected Adults
83. Predictors associated with a better response to the Japanese aluminum‐free hepatitis A vaccine, Aimmugen®, for people living with HIV.
84. Nef‐specific CD107a+ CD4+ T‐cell responses in a rhesus macaque (Macaca mulatta) showing partial simian immunodeficiency virus control following passive neutralizing antibody infusion.
85. Phylodynamic inference of infectious diseases caused by HIV, enterovirus 71 and the 2009 swine-origin human influenza virus
86. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques
87. CRITICAL AMINO ACID RESIDUES FOR FUNCTIONAL INTERACTION BETWEEN N-TERMINAL AND C-TERMINAL DOMAINS IN SIV CAPSID PROTEINS: Abstract #73
88. Human leukocyte antigen-associated gag and nef polymorphisms in HIV-1 subtype A/E-infected individuals in Vietnam
89. Immunophenotyping of Rhesus CMV ‐Specific CD8 T‐Cell Populations
90. Inefficient Tax-Specific T-Cell Responses in Mice after Syngeneic Transplantation with tax-Transgenic Mouse-Derived Adult T-Cell Leukemia Cells
91. Multidrug treatment with nelfinavir and cepharanthine against COVID-19
92. A Novel Immunogen Selectively Eliciting CD8 + T Cells but Not CD4 + T Cells Targeting Immunodeficiency Virus Antigens
93. Identification of Anti-COVID-19 Agents, Cepharanthine and Nelfinavir, and Their Potential Usage for Combination Treatment
94. Determination of a T cell receptor of potent CD8+ T cells against simian immunodeficiency virus infection in Burmese rhesus macaques
95. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network
96. Broadening of CD8+ cell responses in vaccine-based simian immunodeficiency virus controllers
97. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network
98. Comparison of the Expression and Immunogenicity of Wild-Type and Sequence-Modified HIV-1 gag Genes in a Recombinant Sendai Virus Vector
99. Induction of functional T-cell responses in neutralizing antibody-triggered SIV control: 025
100. Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.